I’m writing a piece on accidental diabetes medication misuse in older adults—cases where patients aren’t intentionally noncompliant but take their medications incorrectly due to factors like cognitive decline, dexterity issues, or misunderstanding dosing instructions. This article will focus on how clinicians can identify and prevent these often-overlooked errors. I’m seeking U.S.-based experts with relevant experience, including: • Geriatricians • Endocrinologists • Certified Diabetes Care and Education Specialists (CDCES) • Pharmacists who work directly with older adults managing diabetes If you’re interested in participating, please reply with your name, credentials, title, U.S. location, and a brief description of your experience in this area. Please answer what you can: 1. What are the most common accidental mistakes you see older adults make with their diabetes medications? 2. How often is what looks like “noncompliance” actually due to physical or cognitive limitations? 3. What kinds of impairments (e.g., arthritis, dementia, vision loss) most often lead to medication misuse? 4. Are there particular diabetes medications or delivery methods (e.g., insulin pens vs. syringes) that are more prone to misuse? 5. What are some red flags that might indicate a patient is unintentionally misusing their medications? 6. How can providers distinguish between deliberate nonadherence and unintentional misuse or confusion? 7. What tools, technologies, or strategies have you seen help reduce these errors in older patients? 8. Do you feel current patient education materials are effective for this population? Where do they fall short? 9. If you could change one thing about how we approach medication safety for older adults with diabetes, what would it be?

Looking to speak with Ob-Gyns, Maternal-Fetal and primary care experts

Published on: 9/25/2025

Physicians on Being Employed vs. Self Employed

Published on: 9/27/2025

Seeking U.S.-based experts in pulmonology to comment on innovations in COPD and asthma care I am working on a Medscape article about new approaches to managing COPD and asthma that go beyond standard inhaler therapy. I am seeking U.S.-based pulmonologists, researchers, or physicians with experience in pulmonary medicine to share insights on emerging strategies in clinical practice and research. Questions: What innovations in COPD and asthma care are you seeing beyond pharmacotherapy (e.g., breathing techniques, pulmonary rehab, personalized approaches)? Are you using or researching personalized oxygen protocols? If so, how do they compare with standard oxygen therapy? What role do biologic or precision-medicine therapies play in COPD and asthma management today? What barriers exist in implementing these newer approaches (cost, access, adherence)? How can primary care providers best incorporate or refer for these innovations? Looking ahead, what developments are most promising for improving COPD and asthma outcomes over the next 5 years? Consent Note: By responding, you consent to being quoted in a Medscape article with attribution. Quotes may be lightly edited for clarity, style, and flow. Please disclose any potential conflicts of interest (such as financial relationships with relevant companies or organizations).

Published on: 9/27/2025

A physician to discuss the risk of taking too many medications in middle age

Published on: 9/24/2025

Seeking insights from U.S.-based primary care physicians (family medicine, internal medicine, or general practice)

Published on: 9/27/2025

20 Pitching Tips to Win Media Coverage in 2025

Real Pitches That Landed Coverage on WSJ, Forbes & More…

Top 12 AI Tools For Better Media Pitching

How to Pitch a Journo Request? (A Complete Beginner's Guide)